Positron emission tomography imaging in melanoma and lymphoma
- 1 April 2002
- journal article
- review article
- Published by Elsevier BV in Seminars in Roentgenology
- Vol. 37 (2), 129-139
- https://doi.org/10.1016/s0037-198x(02)80032-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- FDG–PET sensitivity for melanoma lymph node metastases is dependent on tumor volumeJournal of Surgical Oncology, 2001
- Clinical Relevance of Positron Emission Tomography (PET) in Treatment Control and Relapse of Hodgkin's DiseaseStrahlentherapie Und Onkologie, 2001
- Positron emission tomography scanning in malignant melanomaCancer, 2000
- Positron Emission Tomography (PET) for Staging and Evaluation of Response to Treatment in Patients with Hodgkin's DiseaseLeukemia & Lymphoma, 1999
- Whole-body 18F-FDG PET for the evaluation of patients with Hodgkinʼs disease and non-Hodgkinʼs lymphomaNuclear Medicine Communications, 1999
- Extranodal malignant lymphoma: detection with FDG PET versus CT.Radiology, 1998
- Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.Radiology, 1997
- Positron emission tomography in the detection and management of metastatic melanomaMelanoma Research, 1996
- Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1995
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994